A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

Clinical trial NCT04253314 · COMPLETED

Trial details

NCT number: NCT04253314
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)

Start date: 2020-03-13
Primary completion: 2023-02-16
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.